Editas Medicine Announces The FDA Has Cleared Initiation Of The EDIT-301 Clinical Trial

Editas Medicine Announces Transition Of Chief Scientific Officer

Blueprint Medicines Reports Portfolio Milestones and Outlines 2021 Roadmap for Precision Medicine Leadership

Editas Medicine Reports On Recent Progress And Outlook At J.P. Morgan Healthcare Conference

Sage Therapeutics Provides 2021 Corporate Strategy Update at J.P. Morgan Healthcare Conference